BioNTech SE - ADR vs Dell Technologies Inc — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Dell Technologies Inc trades at $450.6 (market cap $284.93B). The key difference: Dell Technologies Inc is far larger — about 12.2× BioNTech SE - ADR's market cap, and Dell Technologies Inc pays a 0.57% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | DELL | |
|---|---|---|
Market Cap | $23.31B | $284.93B |
Sector | Health | Technology |
52-Week High | $119.34 | $467.27 |
52-Week Low | $83.89 | $111.10 |
Enterprise Value | $6.60B | $304.51B |
Dividend Yield | — | 0.57% |
Trailing returns across standard periods
Latest headlines on both assets
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →VMware is an industry titan in virtualizing IT infrastructure and became a stand-alone entity after spinning off from Dell Technologies in November 2021. The software provider operates in the three segments: licenses
Read more on DELL →